​

Tango Therapeutics Ownership | Who Owns Tango Therapeutics?

OverviewForecastRevenueFinancialsChart

Tango Therapeutics Ownership Summary

Tango Therapeutics is owned by 149.60% institutional investors, 1.13% insiders. Rtw investments, lp is the largest institutional shareholder, holding 9.68% of TNGX shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.70% of its assets in Tango Therapeutics shares.

TNGX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTango Therapeutics149.60%1.13%-50.73%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp13.90M9.68%$434.53M
Ecor1 capital10.63M9.62%$89.30M
Blackrock funding, inc. /de12.44M8.66%$388.83M
Fmr12.33M8.59%$385.54M
Farallon capital management12.28M8.55%$383.78M
Boxer capital8.20M7.58%$70.34M
Boxer capital management10.88M7.58%$339.99M
Goldman sachs group9.98M6.95%$311.99M
Tcg crossover management9.08M6.33%$283.88M
Vanguard group6.75M6.08%$59.81M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Trv gp iv6.37M47.37%$120.18M
Boxer capital management10.88M25.61%$339.99M
Acuta capital partners390.95K8.52%$12.22M
Tcg crossover management9.08M6.82%$283.88M
Stempoint capital lp1.22M6.59%$38.23M
Dv equities1.32M5.91%$41.22M
Monashee investment management100.00K5.25%$3.13M
Ecor1 capital10.63M4.29%$89.30M
Commodore capital lp2.25M4.19%$70.33M
Vivo capital1.38M3.94%$43.13M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/6.35M0.02%5.46M
Goldman sachs group9.98M0.03%4.90M
Blackrock funding, inc. /de12.44M0.01%3.69M
Farallon capital management12.28M1.77%3.18M
Perceptive advisors3.38M1.58%2.57M

Top Sellers

HolderShares% AssetsChange
Nextech invest---7.27M
Adage capital partners gp5.60M0.25%-7.21M
Southpoint capital advisors lp---5.00M
Gilead sciences---4.85M
Woodline partners lp4.00M0.39%-4.00M

New Positions

HolderShares% AssetsChangeValue
Commodore capital lp2.25M4.19%2.25M$70.33M
Polar capital1.48M0.11%1.48M$46.29M
Dv equities1.32M5.91%1.32M$41.22M
Sixth street partners management company1.07M0.00%1.07M$33.51M
American century companies1.01M0.01%1.01M$31.69M

Sold Out

HolderChange
Twin peaks wealth advisors-2.00
Nelson, van denburg & campbell wealth management group-12.00
True wealth design-16.00
Mai capital management-18.00
Versant capital management-28.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202625629.29%214,795,04719.16%1490.62%18047.54%56-1.75%
Mar 31, 202674-56.73%20,414,054-88.16%170.07%46-64.06%19-29.63%
Dec 31, 2025103-28.97%65,776,312-53.01%590.37%79-8.14%13-61.76%
Sep 30, 202514117.50%131,410,6723.26%1180.90%8421.74%3317.86%
Jun 30, 2025118-127,240,30347.81%1151.89%6715.52%28-28.21%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor4.40M2.70%529.15K
Vanguard Total Stock Mkt Idx Inv4.40M2.70%529.15K
Vanguard MStar Total Stk Mkt Idx Invest4.41M2.62%13.89K
iShares Russell 2000 ETF3.59M2.20%-63.74K
Fidelity Growth Compy Commingled Pl S3.44M2.11%317.00K
State Street® SPDR® S&P® Biotech ETF2.84M1.74%6.52K
Fidelity Growth Company Fund2.71M1.66%235.06K
Fidelity Growth Compy Commingled Pl O1.69M1.58%-
Fidelity Select Biotechnology2.31M1.42%-32.40K
T. Rowe Price Small-Cap Value1.54M1.39%-117.06K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 01, 2026Crystal Adam President, R&DSell$603.91K
Aug 03, 2026Crystal Adam President, R&DSell$141.10K
Aug 03, 2026Crystal Adam President, R&DSell$594.42K
Jul 01, 2026Crystal Adam President, R&DSell$222.95K
Jul 01, 2026Crystal Adam President, R&DSell$575.96K

Insider Transactions Trends

DateBuySell
2026 Q3-5
2026 Q2-6
2026 Q1-9
2025 Q4-1
2025 Q3-6

TNGX Ownership FAQ

Who Owns Tango Therapeutics?

Tango Therapeutics shareholders are primarily institutional investors at 149.60%, followed by 1.13% insiders and -50.73% retail investors. The average institutional ownership in Tango Therapeutics's industry, Biotech Stocks , is 379.61%, which Tango Therapeutics falls below.

Who owns the most shares of Tango Therapeutics?

Tango Therapeutics’s largest shareholders are Rtw investments, lp (13.9M shares, 9.68%), Ecor1 capital (10.63M shares, 9.62%), and Blackrock funding, inc. /de (12.44M shares, 8.66%). Together, they hold 27.96% of Tango Therapeutics’s total shares outstanding.

Does Blackrock own Tango Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tango Therapeutics.

Who is Tango Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp iv is Tango Therapeutics’s biggest shareholder by percentage of total assets invested, with 47.37% of its assets in 6.37M Tango Therapeutics shares, valued at 120.18M$.

Who is the top mutual fund holder of Tango Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Tango Therapeutics shares, with 2.70% of its total shares outstanding invested in 4.4M Tango Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools